Healthcare / Medical DevicesNasdaqCM
$2.36
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-9.9M · quality 53.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
9/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$5M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-352.7%
↓Gross Margin
40.8%
↓Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2020–2025 · 5 años de histórico normalizado
Revenue CAGR
+74.5%
FCF CAGR
—
FCF margin
-324.6%
FCF / Net income
0.94x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.1M · net income $-10.6M · FCF $-9.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | $3.1M | $3.1M | $3.1M | $1.3M | $437146.00 | $2.0M | $188744.00 |
| Net Income | $-10.6M | $-10.6M | $-10.2M | $-10.6M | $-8.3M | $-7.0M | $-3.2M |
| EBITDA | $-9.7M | $-9.7M | $-9.3M | $-11.8M | — | — | — |
| EPS | -2.00 | -2.00 | -6.38 | -127.00 | -11.33 | -0.68 | — |
| Gross Margin | 40.8% | 40.8% | 45.8% | 26.0% | — | — | — |
| Operating Margin | -348.7% | -348.7% | -330.5% | -1002.1% | -1907.1% | -281.4% | -1513.7% |
| Net Margin | -346.2% | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% | -1676.2% |
| Cash Flow | |||||||
| Free Cash Flow | $-9.9M | $-9.9M | $-9.8M | — | — | — | — |
| Returns | |||||||
| ROE | -352.7% | -352.7% | -121.9% | -279.9% | -125.4% | -46.7% | 61.0% |
| Growth & Yield | |||||||
| Revenue Growth | -1.9% | -1.9% | 147.6% | 187.5% | -77.9% | 949.3% | — |
| EPS Growth | 68.7% | 68.7% | 95.0% | -1020.9% | -1566.2% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.